Easy onboarding We coordinate with your provider and guide you through next steps
It leverages the proven benefits of semaglutide (a GLP-1 receptor agonist) and the innovative microneedle patch drug delivery system to supposedly offer an easy, non-invasive, and highly effective solution for major metabolic health concerns like obesity, diabetes, and heart disease
These two conditions are closely interrelated, with DM representing a significant risk factor for CVD due to factors such as obesity, hypercholesterolemia, atherosclerosis, microcirculation disorders, and hypertension [1, 2]
FierceBiotech (2009)
Heres a quick rundown
They don't want to say something and have me have a bad illness or something, you know, so we have that one